相似文献
1
Patent Foramen Ovale: Story Closed?
J Stroke. 2019 Jan;21(1):23-30. doi: 10.5853/jos.2018.03097. Epub 2019 Jan 31.
2
Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
Am J Med. 2016 Nov;129(11):1159-1162. doi: 10.1016/j.amjmed.2016.08.006. Epub 2016 Aug 24.
3
Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Cerebrovasc Dis. 2018;45(3-4):162-169. doi: 10.1159/000487959. Epub 2018 Mar 29.
4
The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Circ Cardiovasc Interv. 2018 Mar;11(3):e004152. doi: 10.1161/CIRCINTERVENTIONS.117.004152.
5
Patent foramen ovale and cryptogenic stroke: the hole story.
Stroke. 2013 Sep;44(9):2676-8. doi: 10.1161/STROKEAHA.113.001676. Epub 2013 Aug 1.
6
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.
7
Cryptogenic Stroke: To Close a Patent Foramen Ovale or Not to Close?
J Cent Nerv Syst Dis. 2018 Dec 16;10:1179573518819476. doi: 10.1177/1179573518819476. eCollection 2018.
8
Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16.
9
Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
Am J Med. 2018 May;131(5):575-577. doi: 10.1016/j.amjmed.2017.11.027. Epub 2017 Dec 8.
10
Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials.
Curr Cardiol Rep. 2019 Apr 22;21(6):48. doi: 10.1007/s11886-019-1137-5.
引用本文的文献
1
Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial.
J Stroke. 2021 May;23(2):289-292. doi: 10.5853/jos.2021.00647. Epub 2021 May 31.
2
Patent Foramen Ovale Closure: Opportunity Closed in Old Patients?
J Stroke. 2021 May;23(2):147-148. doi: 10.5853/jos.2021.01690. Epub 2021 May 31.
3
A Narrative and Critical Review of Randomized-Controlled Clinical Trials on Patent Foramen Ovale Closure for Reducing the Risk of Stroke Recurrence.
Front Neurol. 2020 Jun 4;11:434. doi: 10.3389/fneur.2020.00434. eCollection 2020.
4
Prior Stroke in PFO Patients Is Associated With Both PFO-Related and -Unrelated Factors.
Front Neurol. 2020 Jun 4;11:503. doi: 10.3389/fneur.2020.00503. eCollection 2020.
5
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with cryptogenic stroke in patients with patent foramen ovale.
Arch Med Sci Atheroscler Dis. 2020 Jun 1;5:e112-e117. doi: 10.5114/amsad.2020.95946. eCollection 2020.
6
Limitations of transoesophageal echocardiogram in acute ischaemic stroke.
Open Heart. 2020 Mar 24;7(1):e001176. doi: 10.1136/openhrt-2019-001176. eCollection 2020.
本文引用的文献
1
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.
Eur Heart J. 2019 Oct 7;40(38):3182-3195. doi: 10.1093/eurheartj/ehy649.
2
Closure of Patent Foramen Ovale and Cryptogenic Stroke: Unresolved Issues.
Curr Neurol Neurosci Rep. 2018 Oct 17;18(12):92. doi: 10.1007/s11910-018-0910-y.
3
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Lancet Neurol. 2018 Dec;17(12):1053-1060. doi: 10.1016/S1474-4422(18)30319-3. Epub 2018 Sep 28.
4
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.
BMJ Open. 2018 Jul 25;8(7):e023761. doi: 10.1136/bmjopen-2018-023761.
5
Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline.
BMJ. 2018 Jul 25;362:k2515. doi: 10.1136/bmj.k2515.
6
Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study.
J Am Heart Assoc. 2018 Jun 17;7(12):e008356. doi: 10.1161/JAHA.117.008356.
7
Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.
Lancet Neurol. 2018 Jul;17(7):609-617. doi: 10.1016/S1474-4422(18)30167-4. Epub 2018 Jun 7.
8
Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review.
Stroke. 2018 Jun;49(6):1541-1548. doi: 10.1161/STROKEAHA.117.018153. Epub 2018 May 14.
9
Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi: 10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12.
10
Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis.
Ann Intern Med. 2018 Mar 6;168(5):335-342. doi: 10.7326/M17-2679. Epub 2018 Jan 9.
Zotero 插件